Safety study of inhaled drug ICF004 in healthy volunteers
Part of Lungs & breathing clinical trials.
This trial tests a new inhaled medication called ICF004 in healthy Chinese adults to see if it is safe and how the body processes it. You can join if you are generally healthy and between 18 and 50 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 50 years old.
- Your body mass index (BMI) is between 18 and 28, and you weigh at least 45-50 kg (depending on gender).
- You do not have any serious medical conditions (including lung, heart, or liver problems).
- You have good lung function (no breathing issues like asthma or COPD) and you can use an inhaler correctly.
- You have not smoked or used e-cigarettes in the last 6 months.
- If you are able to have children, you agree to use effective birth control during the study and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single inhaled dose of RJ026 in patients with interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF) or connective tissue disease-related ILD (CTD-ILD). It helps see how the drug moves through the body and if it's safe.
This trial tests a new medicine called NCR101 for people with interstitial lung disease (a lung condition that causes scarring). It aims to see if the drug is safe and helps slow the disease. You may be able to join if your current treatments are stable.
This study tests a new inhaled drug (MKND-201) in healthy volunteers to see if it's safe and how the body processes it. If you are a generally healthy adult between 40 and 65, you might be able to help researchers understand if this medicine is safe for future studies.
This trial tests the safety of a new inhaled medicine. You must be a healthy nonsmoker, have normal lung function, and agree to avoid certain medications and foods.
This is an early-stage safety study testing a new inhaled medication called RC010 in healthy volunteers. Researchers want to understand how safe it is, how well people tolerate it, and how the body processes it.
This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.
Hear when a new Interstitial Lung Disease (ILD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.